Market revenue in 2020 | USD 36.2 million |
Market revenue in 2027 | USD 61.6 million |
Growth rate | 7.9% (CAGR from 2020 to 2027) |
Largest segment | Autosampler systems |
Fastest growing segment | Autosampler Systems |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Autosampler Systems, Autosampler Accessories |
Key market players worldwide | IQVIA Holdings Inc, Icon PLC, Charles River Laboratories International Inc, Pharmaceutical Product Development |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to autosamplers market will help companies and investors design strategic landscapes.
Autosampler systems was the largest segment with a revenue share of 62.98% in 2020. Horizon Databook has segmented the China autosamplers market based on autosampler systems, autosampler accessories covering the revenue growth of each sub-segment from 2016 to 2027.
In 2017, China Food and Drug Administration (CFDA) became a member of ICH thus, leading to integration of China’s drug regulatory system with the international regulatory standards. This change is anticipated to enable many multinational enterprises to set up their manufacturing units in China. Moreover, few global market players are also expected to form joint venture with firms in China.
CFDA reform is anticipated to improve the level of the quality control and analytical testing required during pharmaceutical drug development and clinical trials studies, in order to support acceleration of regulatory process for new drug approvals. Such supportive reforms are anticipated to fuel the market growth.
Furthermore, increasing drug development activities and collaborations in the country are also anticipated to facilitate the market growth. For instance, according to a study by BioPlan Associates, Inc., nearly 250 monoclonal antibodies are under clinical development in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the China autosamplers market, including forecasts for subscribers. This country databook contains high-level insights into China autosamplers market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account